© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
June 19, 2020
The phase 3 trial evaluating eprenetapopt plus Vidaza completed enrollment recently, and could lead to a new standard of care with positive results, according to Dr. Guillermo Garcia-Manero.
A Patient With Cancer's Gratitude for Clinical Trials
Why Are We So Stressed? Fear Can Be Debilitating for Cancer Survivors
An Oncology Nurse With a Fun Personality Despite Hectic Situations
The Harshest Reality of Cancer You’ll Have to Face